Press release
Global Drug Delivery Technology Market is projected to grow at a CAGR of 7.6% during Forecast Period - Johnson & Johnson, Generex Biotechnology Corporation, Vectura Group plc., Roche, Merck, Bayer, 3M, BD, GSK GROUP OF COMPANIES
Global Drug Delivery Technology Market
The Global Drug Delivery Technology Market is expected to reach USD 7185.08 Billion by 2025, from USD 1268.82 Billion in 2017 growing at a CAGR of 7.6% during the forecast period of 2018 to 2025.
Download exclusive PDF sample report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-delivery-technology-market
Global Drug Delivery Technology Market, By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery Implantable Drug Delivery and Transmucosal Drug Delivery), By Facility of Use (Hospitals, Ambulatory Surgical Centers/Clinics, Home Care Settings, Diagnostic Centers and Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025
Major Market Drivers & Market Restraint: Global Drug Delivery Technology Market
• Widespread presence of chronic diseases
• Growth in the demand of biologics market
• Advancements in technology
• Launch of new product
• Launch of new advanced technologies in emerging markets
• Self-administration & home care
• Risk of needle-stick injuries
• Side effects of drug
• Recalling of products
Competitive Analysis
The global drug delivery technology market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of drug delivery technology market for global, Europe, North America, Asia Pacific and South America.
Note: If you have any special requirements, please let us know and we will offer you the report as you want, Mail us on @
sopan.gedam@databridgemarketresearch.com
Market Segmentation: Global Drug Delivery Technology Market
The global drug delivery technology market is segmented on the basis of route of
• administration,
• facility of use and
• geography
Based on route of administration the market is segmented into
• oral drug delivery,
• pulmonary drug delivery,
• injectable drug delivery ocular drug delivery,
• nasal drug delivery,
• topical drug delivery implantable drug delivery and
• transmucosal drug delivery
Implantable drug delivery is sub-segmented into active implantable drug delivery and passive implantable drug delivery. The transmucosal drug delivery is sub-segmented into oral transmucosal drug delivery and other transmucosal drug delivery. The oral transmucosal drug delivery is further sub-segmented into buccal drug delivery and sublingual drug delivery whereas the other transmucosal drug delivery is further sub-segmented into rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
based on the facility of use, the global drug delivery technology market is segmented into
• hospitals,
• ambulatory surgical centers/clinics,
• home care settings,
• diagnostic centers and other facilities of use
Based on geography the global drug delivery technology market report covers data points for 28 countries across multiple geographies namely
• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others
Inquiry before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-drug-delivery-technology-market
Top Competitors of Market
• Johnson & Johnson Services, Inc.,
• F. Hoffmann-La Roche AG,
• Merck Sharp & Dohme Corp.,
• Bayer AG,
• Pfizer Inc,
• Novartis AG,
• 3M,
• BD,
• Becton,
• Dickinson and Company,
• GSK group of companies,
• Sanofi,
• Antares Pharma,
• Generex Biotechnology Corp.,
• EyePoint Pharmaceuticals,
• Alkermes,
• Aradigm Corporation.,
• Vectura Group plc,
• NanoPass,
• Baxter,
• AstraZeneca,
• Takeda Pharmaceutical Company Limited
For Direct Purchase of this Report, Visit @ https://databridgemarketresearch.com/reports/global-drug-delivery-technology-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Drug Delivery Technology Market is projected to grow at a CAGR of 7.6% during Forecast Period - Johnson & Johnson, Generex Biotechnology Corporation, Vectura Group plc., Roche, Merck, Bayer, 3M, BD, GSK GROUP OF COMPANIES here
News-ID: 1150790 • Views: …
More Releases from Data Bridge Market Research
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period.
Market Overview
This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market…
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.
Market Overview
Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind…
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview
Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which…
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
